A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 39/12 (2006.01) A61P 31/04 (2006.01) C07K 14/25 (2006.01) C12N 15/31 (2006.01)
Patent
CA 2563214
The present invention relates to a composition and a method for eliciting an immunogenic response in animals, including responses that provide protection against, or reduce the severity of shigella infections. More particularly it relates to the use of the IpaD protein obtained from natural sources and/or through synthesis or recombinant technology, and conjugates thereof to induce neutralizing antibodies having protective activity against several serotypes of Shigella, in particular S. flexneri. The composition of the invention is useful to prevent and/or treat shigellosis caused by a bacterium of the Shigella family.
Allaoui Abdelmounaaiem
Boekema J. Egbert
Botteaux Anne
Parsot Claude
Sani Musa
Allaoui Abdelmounaaiem
Boekema J. Egbert
Botteaux Anne
Institut Pasteur
Parsot Claude
LandOfFree
Shigella ipad protein and its use as a potential vaccine... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Shigella ipad protein and its use as a potential vaccine..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Shigella ipad protein and its use as a potential vaccine... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1945611